Join The MoviMent

Sign up to join The MoviMent (Returning member?)

Millions of Americans are taking a stand against colon cancer and choosing to get a colonoscopy. We are pleased to support the movement by providing you with premium resources that will help you prepare for your procedure.

Please enter your information in the form below. Click on Join The MoviMent when you are finished. All fields with an asterisk (*) are required.

  1. First name must be at least 2 characters.
  2. Last name must be at least 2 characters.
  3. E-mail must be a valid address.
  4. Must match the other e-mail value.
  5. User name must be at least 2 characters.
  6. Password must be at least 7 characters.
  7. Must match other password value.
  8. Please select a profession.
  9. Please select a Profession/Specialty.
I certify that I am 18 years of age or older and a resident of the United States.
Must certify your age and residency status.
Yes! I am also interested in receiving additional communications (health tips, wellness tools, coupons and other discounts, educational materials, product information, etc) from Salix Pharmaceuticals.

All personal information will be kept confidential and will not be shared with any third parties other than Salix Pharmaceuticals and its designated partners.
View our full Privacy Policy.

When you join The MoviMent, you will be able to download the My MoviMent Prep Kit.

Theincludes
An easy-to-read guide that will teach you what you will need to know when preparing for your colonoscopy
A customizable colonoscopy calendar
Tips for making the prep more tolerable
Games and puzzles to help you pass the time during your prep
A guide for the day of your procedure
And much more

Important Safety Information about MOVIPREP

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients with gastrointestinal (GI) obstruction, bowel perforation, gastric retention, ileus, toxic colitis or toxic megacolon, and patients who have had a severe hypersensitivity reaction to any of its components. MOVIPREP should be used with caution in patients at risk of or with fluid and electrolyte abnormalities, hyponatremia, arrhythmias, seizures, in patients with impaired renal function or patients taking concomitant medications that affect renal function, patients with known or suspected inflammatory bowel disease, patients with suspected GI obstruction or perforation, patients at risk for aspiration, and patients with glucose-6-phosphate dehydrogenase deficiency. Most common adverse reactions for split dosing (incidence ≥5%) are malaise, nausea, abdominal pain, vomiting, and upper abdominal pain. The most common adverse reactions for evening only dosing (incidence ≥5%) are abdominal distension, anal discomfort, thirst, nausea, abdominal pain, sleep disorder, rigors, hunger, malaise, vomiting, and dizziness. MOVIPREP contains 233 mg of phenylalanine per treatment. Advise patients to hydrate adequately before, during, and after the use of MOVIPREP.

You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/safety/medwatch or call 1-800-FDA-1088.

Complete Prescribing Information pdf-icon

For Dummies is a registered trademark of Wiley Publishing, Inc.